Athenex to participate in the h.c. wainwright 24th annual global investment conference

Buffalo, n.y., sept. 06, 2022 (globe newswire) --  athenex (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will present at the h.c. wainwright 24th annual global investment conference, taking place september 12-14, 2022, in new york, ny and virtually. company management will also be available for one-on-one investor meetings during the event. please find additional details about the presentation below.
ATNX Ratings Summary
ATNX Quant Ranking